Xadago 50 mg & 100 mg Tablets
PDF Leaflet Revision Date: 24 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Add-on therapy for adult patients with idiopathic Parkinson's disease.
Dosage (summary)
Start at 50 mg/day, may increase to 100 mg/day based on clinical need. No change for elderly.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding due to potential risks.
Key Drug Interactions
- MAO inhibitors
- Pethidine
- SSRIs
- SNRIs
Contraindications
- Hypersensitivity to safinamide
- Severe hepatic impairment
- Concomitant MAO inhibitors
- Concomitant pethidine
Common side effects
- Dyskinesia
- Somnolence
- Dizziness
- Nausea
Counselling Points
- Take with or without food
- Monitor for impulse control disorders
- Avoid driving if affected by somnolence
Serious warnings
- Risk of serotonin syndrome
- Impulse control disorders
- Potential retinal degeneration
Important Disclaimer
The Xadago 50 mg & 100 mg Tablets professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
